SCHEMBL4421062

SCHEMBL4421062

CCCCCCCCCCCCCCCCOC(=O)/C=C/c1ccccc1OC

nearest known ligand 0.71

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.71
ALDH1A1 P00352 4/20 0.71
HPGD P15428 3/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
NFE2L2 Q16236 2/20 0.58
TFEB P19484 1/20 0.57
AKR1B10 O60218 5/20 0.56
AKR1B1 P15121 5/20 0.56
KMT2A Q03164 2/20 0.55
MAPT P10636 2/20 0.55
APP P05067 4/20 0.54
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.52
LMNA P02545 1/20 0.52
BCHE P06276 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629237 1.00 KDM4E (0.71) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL466048 1.00 KDM4E (0.71) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL8872224 1.00 KDM4E (0.71) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL8872479 1.00 KDM4E (0.71) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
Hydrochloric Acid SCHEMBL10437236 0.99 KDM4E (0.73) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL5177689 0.99 KDM4E (0.73) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL1614877 0.96 KDM4E (0.73) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL19244312 0.96 KDM4E (0.73) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL19244433 0.90 KDM4E (0.72) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2
SCHEMBL2474892 0.90 KDM4E (0.72) KDM4EALDH1A1HPGDSMN1; SMN2NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10370657-B2 Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene CURNA, INC. (US) 2019-08-06 US disclosed
US-20170073680-A1 TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENE CURNA, INC. 2017-03-16 US disclosed
EP-1187598-B1 MICROPIGMENT MIXTURE BASF SE (DE) 2009-10-21 EP disclosed